-
DEVELOPING A PROOF-OF-CONCEPT WORKFLOW COMBINING AI-DRIVEN HTA COMMITTEE SIMULATION AND AI-GENERATED PAYER QUESTIONNAIRES FOR PROACTIVE PRICING AND ACCESS PLANNING
Aug 11, 2026, 17:16 PM -
PROJECTED WIDER SOCIETAL AND FISCAL IMPACT OF SEMAGLUTIDE IN THE UNITED KINGDOM
Aug 11, 2026, 17:16 PM -
COPD IN IRELAND THROUGH THE PATIENT LENS: REPORTED EXPERIENCES, PROGRESS, AND CHALLENGES
Aug 11, 2026, 17:16 PM -
BEYOND SINGLE-MODEL SURROGACY: A MULTI-MODEL EVALUATION OF PROGRESSION-FREE SURVIVAL AS A TRIAL-LEVEL SURROGATE FOR OVERALL SURVIVAL IN RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA
Aug 11, 2026, 17:16 PM -
SICK IN THE CITY? REGIONAL DIFFERENCES AND CAUSES OF SICK LEAVE IN GERMANY: CLAIMS DATA INSIGHTS AND ANALYTICAL OPPORTUNITIES
Aug 11, 2026, 17:16 PM -
CHARACTERIZING RESMETIROM INITIATORS IN THE IMMEDIATE POST-APPROVAL PERIOD: ADHERENCE AND PERSISTENCE, AND HEALTHCARE COSTS FROM A US CLAIMS DATABASE
Aug 11, 2026, 17:16 PM -
OUTCOMES IN INFLUENZA PHASE III/IV CLINICAL TRIALS: A SCOPING REVIEW
Aug 11, 2026, 17:16 PM -
REAL-WORLD (RW) CLINICAL OUTCOMES AND CORRELATION OF RECURRENCE FREE SURVIVAL (RFS) AND DISTANT METASTASIS SURVIVAL (DMFS) TO OVERALL SURVIVAL (OS) IN RESECTED STAGE III-IV CUTANEOUS MELANOMA
Aug 11, 2026, 17:16 PM -
HEALTHCARE RESOURCE USE OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) EXACERBATIONS: A RETROSPECTIVE ANALYSIS OF GERMAN CLAIMS DATA
Aug 11, 2026, 17:16 PM -
VALIDATION OF AN AGENTIC AI-ASSISTED EVIDENCE-TO-MODEL WORKFLOW USING A PUBLISHED BUDGET IMPACT MODEL DEVELOPMENT: A COMPARATIVE EVALUATION
Aug 11, 2026, 17:16 PM -
MAPPING EPIDEMIOLOGICAL EVIDENCE AND PRIMARY MUTATION LANDSCAPE OF LEBER HEREDITARY OPTIC NEUROPATHY USING AI-ENABLED EVIDENCE SYNTHESIS
Aug 11, 2026, 17:16 PM -
ANTIFUNGAL-ASSOCIATED ACUTE KIDNEY INJURY: A DISPROPORTIONALITY ANALYSIS AND SYSTEMATIC REVIEW
Aug 11, 2026, 17:16 PM -
BEYOND THE MARGIN: WHY THE NHS MEAN COST PER QALY MAY EXCEED THE RECENTLY ELEVATED NICE THRESHOLD
Aug 11, 2026, 17:16 PM -
CAPACITY BUILDING OR CONCENTRATION? EARLY PATTERNS OF ASSESSOR AND CO-ASSESSOR PARTICIPATION IN EUROPEAN UNION JOINT CLINICAL ASSESSMENTS
Aug 11, 2026, 17:16 PM -
CLINICIAN GLOBAL IMPRESSION OF SEVERITY AND CHANGE SCALES FOR CUTANEOUS LUPUS ERYTHEMATOSUS: COGNITIVE DEBRIEFING EVIDENCE SUPPORTING CLINICAL UTILITY
Aug 11, 2026, 17:16 PM -
TOWARD AI-AUGMENTED SCREENING FOR HTA-RELEVANT EVIDENCE SYNTHESIS: VALIDATION OF A GOVERNED SINGLE-REVIEWER WORKFLOW
Aug 11, 2026, 17:16 PM -
REAL-WORLD DATA ON INTRAVENOUS AND ORAL ANTINEOPLASTIC TREATMENTS OVER 20 YEARS (2005-2024) AT A TERTIARY HOSPITAL
Aug 11, 2026, 17:16 PM -
COMPARISON OF POPULATION-ADJUSTMENT METHODS FOR INDIRECT TREATMENT COMPARISONS - A CASE STUDY IN PLAQUE PSORIASIS
Aug 11, 2026, 17:16 PM -
ADVERSE EVENTS IN ROMANIAN HOSPITALS 2017-2024: A NATIONAL LONGITUDINAL ANALYSIS OF NATIONAL AUTHORITY FOR QUALITY MANAGEMENT IN HEALTH - REPORTED INCIDENTS
Aug 11, 2026, 17:16 PM -
TRANSLATING EVIDENCE FROM CONTINUOUS OUTCOMES INTO TRANSITION PROBABILITIES IN MARKOV MODELS: A SYSTEMATIC REVIEW OF CURRENT PRACTICE AND METHODOLOGICAL GAPS IN HEALTH TECHNOLOGY ASSESSMENT
Aug 11, 2026, 17:16 PM
